No connection

Search Results

INMD vs OPK

INMD
InMode Ltd.
NEUTRAL
Price
$13.53
Market Cap
$857.2M
Sector
Healthcare
AI Confidence
85%
OPK
OPKO Health, Inc.
BEARISH
Price
$1.18
Market Cap
$905.9M
Sector
Healthcare
AI Confidence
85%

Valuation

P/E Ratio
INMD
9.46
OPK
--
Forward P/E
INMD
8.84
OPK
-3.58
P/B Ratio
INMD
1.25
OPK
0.71
P/S Ratio
INMD
2.31
OPK
1.49
EV/EBITDA
INMD
3.6
OPK
-7.29

Profitability

Gross Margin
INMD
78.53%
OPK
13.5%
Operating Margin
INMD
25.03%
OPK
-28.98%
Profit Margin
INMD
25.33%
OPK
-37.19%
ROE
INMD
13.53%
OPK
-17.14%
ROA
INMD
6.88%
OPK
-6.62%

Growth

Revenue Growth
INMD
6.1%
OPK
-19.2%
Earnings Growth
INMD
-63.5%
OPK
--

Financial Health

Debt/Equity
INMD
0.01
OPK
0.31
Current Ratio
INMD
9.88
OPK
3.97
Quick Ratio
INMD
8.55
OPK
3.21

Dividends

Dividend Yield
INMD
--
OPK
--
Payout Ratio
INMD
0.0%
OPK
0.0%

AI Verdict

INMD NEUTRAL

InMode presents a classic 'value trap' profile, characterized by a weak Piotroski F-Score of 3/9 and a completely bearish technical trend (0/100). While the company maintains an exceptional balance sheet with virtually no debt (Debt/Equity 0.01) and extreme liquidity (Current Ratio 9.88), these strengths are offset by a severe collapse in earnings growth (-63.50% YoY). The stock trades below its Graham Number ($18.63) but above its growth-based intrinsic value ($10.01), suggesting that while it is cheap on a book-value basis, its growth trajectory is deteriorating.

Strengths
Exceptional gross margins of 78.53%
Virtually debt-free balance sheet (Debt/Equity 0.01)
Extreme short-term liquidity with a Current Ratio of 9.88
Risks
Severe earnings contraction (-63.50% YoY)
Strongly bearish technical momentum (0/100 trend score)
Deteriorating fundamental health as indicated by Piotroski F-Score (3/9)
OPK BEARISH

OPK exhibits severe fundamental weakness, highlighted by a Piotroski F-Score of 1/9, indicating critical failures in profitability and operational efficiency. While the company maintains a strong liquidity position with a current ratio of 3.97 and low debt, these are offset by a -19.2% decline in year-over-year revenue and deeply negative profit margins. The stock is trading below its book value (P/B 0.71), but the persistent long-term price decay (-72.8% over 5 years) suggests a value trap rather than a bargain. Despite optimistic analyst price targets, the deterministic data points to a company in structural decline.

Strengths
Strong short-term liquidity (Current Ratio 3.97)
Low leverage (Debt/Equity 0.31)
Trading at a discount to book value (P/B 0.71)
Risks
Severe operational weakness (Piotroski F-Score 1/9)
Significant revenue contraction (-19.2% YoY)
Deeply negative profit margins (-37.19%)

Compare Another Pair

INMD vs OPK: Head-to-Head Comparison

This page compares InMode Ltd. (INMD) and OPKO Health, Inc. (OPK) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile